European Medicines Agency workshop on pharmacogenomics: from science to clinical care

• Date:
  Monday, 8 October 2012, All day
• Location:
  European Medicines Agency, Amsterdam, the Netherlands

This workshop's topics include current methodological, regulatory and public health implication of pharmacogenomics from drug discovery, medicines evaluation to clinical use. Its objectives are to share international expert views, discuss challenges and identify areas for joint stakeholder action. Registration closed.

Documents

Agenda - Workshop on pharmacogenomics: from science to clinical care

Reference Number: EMA/324423/2012

European Medicines Agency workshop on pharmacogenomics: from science to clinical care - Invitation for expressions of interest

Reference Number: EMA/47793/2012

Report - European Medicines Agency workshop on pharmacogenomics

Reference Number: EMA/683241/2012

Presentation - Genomics in science and clinical care

Presentation - Pharmacogenomics in rare diseases: Development strategy for ivacaftor as a therapy for cystic fibrosis

Presentation - Guideline on the use of pharmacogenetic methodologies in the pharmacokinetic evaluation of medicinal products

Presentation - Clinical pharmacogenomics: Premarketing evaluation in early-phase clinical studies

Presentation - Methodological issues (some) relating to patient selection - CHMP reflection paper

Presentation - Adaptive designs for the development of targeted therapies

Presentation - Evaluation and implementation challenges with genomic signatures in clinical drug development

Presentation - Opportunities for public health and pharmacogenomics from the new pharmacovigilance legislation

Presentation - Concept paper on key aspects for the use of pharmacogenomic methodologies in the pharmacovigilance evaluation of medicinal products

Presentation - Session 3: Post-approval pharmacogenomics: impact on risk management

Presentation - Pharmacogenomics: a long(er) learning curve?

Presentation - Session 4 : Pharmacogenomics-guided treatments in clinical care: experience from patients and healthcare professionals

Presentation - Pharmacogenetic clinical implementation: a seven-year experience

Presentation - Revision of the European Union Directive on in-vitro diagnostic medical devices

Presentation - Regulation, innovation and personalised medicine

Presentation - Health-technology assessment of companion diagnostics

Presentation - Genomics in patients with Hispanic ancestry

Presentation - Genomics in patients with Japanese ancestry

Presentation - Differences in a biomarker’s predictive ability across racial groups

Multimedia